首页 | 本学科首页   官方微博 | 高级检索  
     

Crohnology: A tale of time and times and inflammatory bowel diseases
引用本文:Gomollón F,Gisbert JP,Gassull MA. Crohnology: A tale of time and times and inflammatory bowel diseases[J]. World journal of gastroenterology : WJG, 2008, 14(36): 5489-5490. DOI: 10.3748/wjg.14.5489
作者姓名:Gomollón F  Gisbert JP  Gassull MA
摘    要:Time, times and timing are key words in inflammatory bowel diseases (IBD). The leifmotif of this issue or World Journal of Gastroenterology is time. We have asked experts to review on the epidemiology of these diseases over time, the changes in innate immunity that could be present in the first time, and then the timing of key treatments. The correct time of using azathioprine, mercaptopurine, infliximab, cyclosporine and surgery are reviewed. We have chosen experts with not only great clinical expertise but also personal interest in clinical and basic investigation. Our goal in this monograph is to get an idea not only of the present but of the immediate future in some of the key management issues in IBD. To this end, we think that the authors are the most adequate.

关 键 词:肠炎  流行病学  先天免疫  治疗
收稿时间:2008-07-29

Crohnology: a tale of time and times and inflammatory bowel diseases
Gomollón Fernando,Gisbert Javier P,Gassull Miquel Angel. Crohnology: a tale of time and times and inflammatory bowel diseases[J]. World journal of gastroenterology : WJG, 2008, 14(36): 5489-5490. DOI: 10.3748/wjg.14.5489
Authors:Gomollón Fernando  Gisbert Javier P  Gassull Miquel Angel
Affiliation:[1]Hospital Clinico Universitario, Zaragoza,Spain; Centro de Investigaci6n Biom6dica en Enfermedades Hepáticas y Digestivas, CIBEREHD, IACS, Spain [2]Hospital Universitario de la Princesa,CIBEREHD, Madrid, Spain [3]Instituto de Investigacion en Cienciasde la Salud, Fundacion Germans Trias i Pujol, CIBEREHD,Badalona, Spain
Abstract:Time, times and timing are key words in inflammatory bowel diseases (IBD).The leifmotif of this issue or World Journal of Gastroenterology is time. We have asked experts to review on the epidemiology of these diseases over time,the changes in innate immunity that could be present in the first time, and then the timing of key treatments. The correct time of using azathioprine, mercaptopurine, infliximab, cyclosporine and surgery are reviewed.We have chosen experts with not only great clinical expertise but also personal interest in clinical and basic investigation. Our goal in this monograph is to get an idea not only of the present but of the immediate future in some of the key management issues in IBD. To this end, we think that the authors are the most adequate.
Keywords:Inflammatory bowel diseases  Epidemio Iogy  Innate immunity  Treatment
本文献已被 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号